Plantable Health Inc.
PLBL.NE · NEO
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | 7.5% | -1.9% | 16.7% | – |
| Cost of Goods Sold | CA$0 | CA$0 | CA$0 | CA$0 |
| Gross Profit | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 24.2% | 16.3% | 19% | 3.9% |
| R&D Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| G&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| SG&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Sales & Mktg Exp. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Income | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| % Margin | -245.8% | -125.6% | -32.2% | -74.9% |
| Other Income/Exp. Net | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Pre-Tax Income | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Tax Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Income | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| % Margin | -251.2% | -411.4% | -42.8% | -104.8% |
| EPS | -0.048 | -0.073 | -0.008 | -0.014 |
| % Growth | 34.3% | -845.5% | 45% | – |
| EPS Diluted | -0.048 | -0.073 | -0.008 | -0.014 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Interest Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Depreciation & Amortization | CA$0 | CA$0 | CA$0 | CA$0 |
| EBITDA | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| % Margin | -236.1% | -115.4% | -22.3% | -65.3% |